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ABSTRACT: Animal venom peptides are currently being developed as novel drugs and 
bioinsecticides. Since ants use venoms for defence and predation, venomous ants represent 
an untapped source of potential bioactive toxins. This study compared the protein and 
peptide components of the poneroid ants Neoponera commutata, Neoponera apicalis, and 
Odontomachus hastatus, and the formicoid ants Ectatomma tuberculatum, Ectatomma 
brunneum and Myrmecia gulosa. 1D and 2D PAGE revealed venom proteins in the mass 
range <10 kDa to >250 kDa. NanoLC-ESI-QTOF MS/MS analysis of tryptic peptides revealed 
the presence of common venom proteins but also many undescribed proteins. RP-HPLC 
separation followed by MALDI-TOF MS of the venom peptides also revealed considerable 
heterogeneity. It was found that the venoms contained between 144–1032 peptides with 5–
95% of peptides in the ranges 1–4 kDa and 1–8 kDa for poneroid and formicoid ants, 
respectively. By employing the reducing MALDI matrix 1,5-diaminonapthalene, up to 28 
disulfide-bonded peptides were also identified in each of the venoms. In particular, the mass 
range of peptides from poneroid ants is lower than peptides from other venoms, indicating 
possible novel structures and pharmacologies. These results indicate that ant venoms 
represent an enormous, untapped source of novel therapeutic and bioinsecticide leads. 
KEYWORDS: Hymenoptera, toxin, proteomic analysis, mass spectrometry, peptidome, ant 
venom, LC-MALDI-TOF MS, nanoLC-ESI-QTOF MS/MS 
 
INTRODUCTION  
Arthropod venoms contain a vast number of insecticidal peptide toxins that are yet to be 
characterised. The current estimate for the numbers of uncharacterised bioactive peptides 




venoms are even less characterised; out of a total of 9000 stinging species, only 11 species 
have been investigated3, 4. 
Ants and other stinging insects, such as Apoidea (bees) and Vespoidea (wasps), belong 
to the family Formicidae of the order Hymenoptera5. Ants represent a diverse group of 
arthropods6, with approximately 13,000 extant species7 and an estimated total of 25,000 
described and undescribed species8, 9. Ants are considered leading invertebrate predators, 
with some adapted to prey upon certain groups of insects using their venom10. However, 
their venom is also used for other purposes including defence against predators and social 
communication11. The success of ants is reflected by their representation of 15–20% of the 
rainforest animal biomass12. 
The limited work done thus far reveals that ant venoms show enormous chemical 
diversity comprising alkaloids, hydrocarbons, proteins and peptides3, 4. Most studies on ant 
venoms have focused on the alkaloidal components, as these are a major cause of allergic 
reactions due to their histamine-releasing properties13, 14. However, more recent studies 
have shown the involvement of the proteome in eliciting these allergic15, 16 and anti-
inflammatory17, 18 properties. Additional studies have also revealed that the peptidome is a 
source of antimicrobial activity against both Gram-positive and Gram-negative bacteria6, 11. 
Neurotoxic ant venom peptides have also been identified and appear to be important for 
defence and prey capture 19. This is an extremely understudied area of research, as only two 
neurotoxic ant peptides have been extensively characterised; poneratoxin20, 21 and 
ectatomin 22.  
The limited number of studies on ant peptides reveal that they either linear (e.g. 
pilosulin), homo- or heterodimeric (e.g. ectatomins), or contain an inhibitor cystine knot 




amount of venom secreted by ants, which makes it difficult to extract sufficient material for 
proper purification and characterisation24. However, the previous lack of high sensitivity 
analytical tools6 has recently been overcome by improvements in mass spectrometric 
instrumentation25, 26.  
While the number of biologically active peptides from all described venomous animal 
species is estimated to approach 20 million, to-date only 75 peptides are described from ant 
venoms3, 4, 25. Consequently, ants are an understudied source of neurotoxic peptides that 
could be used as leads for novel bioinsecticidal compounds. Strong indicators include the use 
of their venom for predation and defence against other insects27, and the presence of 
disulfide-rich, low molecular weight peptides3, 4. These types of peptides are readily 
absorbed, highly stable and resistant to degradative environmental factors28, 29. Given the 
limited investigation of ant venoms this study aimed to investigate the complexity of the 
protein and peptide components of six different ant venoms from the two major ant clades: 
formicoids and poneroids. The present study found that ant venoms are, indeed, rich in both 
peptides and proteins that could serve as potential sources of structurally and 
pharmacologically novel neurotoxins. These could be mined for potential biopesticides to 
control agricultural pests and insect vectors that transmit diseases.  
 
EXPERIMENTAL SECTION 
Ant Collection and Taxonomy 
Live specimens of worker ants from the poneroid species Neoponera commutata, 
Neoponera apicalis and Odontomachus hastatus (Ponerinae) and the formicoid species 
Ectatomma tuberculatum and Ectatomma brunneum (Ectatomminae) were collected from 




the venom glands. Dissected glands from an individual species were pooled in 10% 
acetonitrile (ACN) in water (v/v). Samples were centrifuged for 5 min at 14,400 rpm (12,000 
gav). The supernatant was then collected and lyophilised prior to storage at –20°C. 
Lyophilised Myrmecia gulosa (formicoid clade; Myrmeciinae) venom was purchased from 
Southwestern Biological Institute (Flagstaff, AZ, USA). All chemicals used were of analytical 
grade and sourced from Sigma-Aldrich Pty Ltd (Castle Hill, NSW, Australia). All buffers were 
prepared using milli-Q water. 
Protein Assay 
Protein quantification was performed using a QuantiPro BCA Assay Kit (Sigma-Aldrich) or 
Qubit Protein Assay Kit (Invitrogen, Mulgrave, Victoria, Australia) with the Qubit 2.0 
fluorometer as per the manufacturer’s instructions using bovine serum albumin (BSA) as the 
standard. 
One-dimensional gel electrophoresis 
100 μg of crude venom samples were mixed with 12 µl SDS sample buffer (15 mM Tris, pH 
6.8; 0.25% (w/v) SDS; 0.25% (v/v) β-mercaptoethanol; 2.5% (v/v) glycerol and 0.0025% (w/v) 
bromophenol blue) and boiled as previously described30. Samples were then centrifuged at 
16,873 gav for 5 min before being loaded into a 4–20% Criterion TGX gel (Bio-Rad, Gladesville, 
NSW, Australia) and electrophoresed in Tris-glycine-SDS running buffer (Bio-Rad) alongside 
Precision Plus ProteinTM standards (Bio-Rad). The gel was run for approximately 30 min at 
300 V, until the dye front reached the bottom of the gel. The gel was then placed in a fixing 
solution containing 40% (v/v) methanol and 10% (v/v) acetic acid for 30 min at room 
temperature before staining with Flamingo fluorescent stain (Bio-Rad) for one hour. After 
staining, the gel was scanned using a Molecular Imager PharosFX Plus system (Bio-Rad) with 




additionally stained with Coomassie Blue G250 overnight then destained with 1% (v/v) acetic 
acid for 2 h. 
Two-dimensional gel electrophoresis 
300 µg samples of N. commutata and E. tuberculatum venom were re-suspended in 100 µl 7 
M urea, 2 M thiourea, 1% (v/v) C7BzO, 50 mM Tris HCl pH 8.8 before reduction and alkylation 
of disulphide bonds with 5 mM tributylphosphine and 20 mM acrylamide monomers for 90 
min. The venom was then desalted using a BioSpin column (Bio-Rad) equilibrated in 7 M 
urea, 2 M thiourea, 1% (v/v) C7BzO. The sample was subjected to 2D-PAGE as previously 
described31. Briefly, sample was fractionated by isoelectric focusing on an 11 cm pH 3–10 IPG 
strip (Bio-Rad) for 100 kVh and then separated on a second dimension on a 4–20% gel. The 
gels were subsequently visualised by staining with Flamingo Gel Stain or Coomassie Blue 
G250 as per section 2.3.1. 
Protein Identification 
Gel spots or bands were excised, digested as previously described32 and subjected to 
nanoLC-ESI-QTOF MS/MS. In brief, tryptic digests of proteins in gel spots or bands were 
placed on a Tempo nanoLC system (Eksigent, Waverley, Victoria, Australia) and loaded onto 
a Michrom reversed-phase trapping cartridge at a rate of 20 μl/min with MS loading solvent, 
consisting of 2% acetonitrile (ACN) and 0.2% trifluoroacetic acid (TFA), onto a C8 trap column 
(Michrom Biosciences, USA). The samples were eluted at 300nl/min onto a 75 μm x 150 mm 
PicoFrit column (New Objective, USA) packed with Magic C18AQ chromatography resin 
(Bruker-Michrom Biosciences, Auburn, CA, USA). Peptides were eluted from the column and 
into the source of a QSTAR Elite hybrid quadrupole-time-of-flight mass spectrometer (AB 
SCIEX, Framingham, MA, USA) using the following program: 5-50% MS solvent B (98% ACN + 




2 minutes, 80-5% for 3 min. MS solvent A was 2% ACN + 0.2% formic acid. The eluting 
peptides were ionised with a 75 µm ID emitter tip that tapered to 15 µm (New Objective) at 
2300V. An Intelligent Data Acquisition (IDA) experiment was performed, with a mass range 
of 375–1500 Da continuously scanned for peptides of charge state 2+–5+ with an intensity of 
more than 30 counts/s. Selected  peptides were fragmented and the product ion fragment 
masses measured over a mass range of 100–1500 Da. The mass of the precursor peptide was 
then excluded for 15 s.  
The MS/MS data files produced by the QSTAR were searched using Mascot Daemon (version 
2.4, provided by the Walter and Elisa Hall Institute33) and searched against the LudwigNR 
database (comprised of the UniProtKB, plasmoDB and Ensembl databases vQ215; 
19,375,804 sequences with 6,797,271,065 residues) with the following parameter settings. 
Fixed modifications: none. Variable modifications: propionamide C, oxidised M, deamidation 
NQ. Enzyme: semi-trypsin. Number of allowed missed cleavages: 3. Peptide mass tolerance: 
100 ppm. MS/MS mass tolerance: 0.2 Da. Charge state: 2+, 3+ and 4+. MS/MS data files were 
also searched against Hymenopteran proteins in the NCBInr protein database using PEAKS 6 
software (Bioinformatics Solutions Inc., Waterloo, ON, Canada). The results from both 
searches were then filtered by including only protein hits with at least one unique peptide. 
Peptides identified by PEAKS 6 were further validated by manual inspection of the MS/MS 
spectra for the peptide to ensure the b- and y-ion series were sufficiently extensive for an 
accurate identification. 
C18 Crude Venom RP-HPLC Fractionation 
Lyophilized crude venom was separated using a Vydac analytical C18 RP-HPLC column 




venom peptide components was achieved using a linear gradient of two mobile phases: 0.1% 
(v/v) trifluoroacetic acid (TFA) in water (solvent A) and 0.085% (v/v) TFA in ACN (solvent B). 
For all venoms except E. brunneum, separation was achieved using a flow rate of 1 ml/min 
with the following gradient of: 0–5 min, 0% solvent B; 5–65 min, 0–60% B; 65–75 min, 60–
90% B; 75–80 min, 90% B; 80–85 min, 90–0% B; and 85–90 min, 0% B. For E. brunneum 
venom separation used a slightly longer gradient to facilitate isolation of the more 
hydrophobic peptides comprising: 0–10 min, 5% solvent B; 10–80 min, 5–70% B; 80–90 min, 
70–95% B; 90–95 min, 95% B; 95–100 min, 95–5% B; and 100–105 min, 5% B. Peaks were 
monitored at absorbances of 280 nm and 215 nm and manually collected, then lyophilised 
and stored at –20oC for further use. 
MALDI-TOF MS Analysis 
MS analysis of the HPLC fractions was performed on a AB SCIEX 5800 MALDI-TOF/TOF mass 
spectrometer. Initial experiments were performed using several MALDI matrices on E. 
tuberculatum HPLC fractions to test for optimum peptide ionisation and crystallisation. The 
four matrices tested were: 5 mg/ml of α-cyano-4-hydroxycinnamic acid (CHCA) dissolved in 
1% (v/v) TFA/100% (v/v) ACN/0.1 M NH4H2PO4 (45/45/10); 10 mg/ml ferulic acid (FA) in 40% 
(v/v) ACN/10 mM serine; 10 mg/ml N-tert-butyl-N-isopropyl-N-methylammonium α-cyano-4-
hydroxycinnamate (ionic CHCA) in 0.1% (v/v) formic acid/50% (v/v) ACN; and a 1:1 mixture of 
CHCA and FA. All venom fractions were reconstituted with 10 µl water. Then, 1 µl of each 
fraction was overlaid with 0.5–0.75 µl of the matrix using the dried droplet method 34. Each 
spectrum was calibrated externally using a mixture of peptides with known molecular 
masses in the same m/z range (AB SCIEX). Mass spectra were acquired in linear mode over 
the range 1,000–10,000 m/z with 400 laser shots accumulated for each sample, based on the 




positive ion mode and signals below 1,000 m/z were not recorded as they were comprised of 
mostly matrix-related ion clusters 35. 
Identification of Disulfide-Bonded Peptides 
Disulfide-bonded peptides were identified by chemical reduction of HPLC fractions. RP-HPLC 
fractions were spotted onto a MALDI plate as detailed in Section 2.4.1 and overlaid with the 
reducing matrix 1,5-diaminonapthalene (1,5-DAN; 10 mg/ml) in 0.05% (v/v) formic acid/50% 
(v/v) ACN36. The matrix was always prepared immediately before use due to the instability of 
1,5-DAN in ACN. All MALDI-TOF data collected using 1,5-DAN or CHCA matrix were acquired 
in reflector mode to isotopically resolve ions for comparison purposes. Chemical reduction 
results in a mass increase of 2 Da for each disulfide bond. Thus, by comparing the mass 
spectra of native and reduced samples the number of disulfide bonds in ant venom peptides 
could be determined. 
Data analysis 
Data Explorer® v4.11 software (AB SCIEX) was used to analyse spectra from individual RP-
HPLC fractions to characterise the number and masses of peptides per venom, as previously 
reported37. Briefly, spectra were subjected to baseline correction with a correlation factor of 
0.7 and Gaussian smoothing to reduce noise with a 5-point filter width. All mass attributions 
were verified manually and a mass list created for each LC-MALDI-TOF MS run. Potential 
adducts from oxidation, hydration, sodium, and deamination were manually removed from 
all mass lists, as well as any potential dimers or doubly-charged species. Peptides with mass 
matches within ±1.0 Da in adjoining HPLC fractions were considered identical and were 
removed from the data set as they likely reflect incomplete separation. For each venom, the 
peptides from each RP-HPLC fraction were consolidated into one mass list. Mass matching 




peptides across the different venoms or between different data sets of the same venom 
when comparing matrices. Two-dimensional scatter plots, termed "2D venom landscapes", 
were constructed using Prism v6 software (GraphPad, La Jolla, CA USA). All peptide masses 
detected in each HPLC fraction were plotted as a function of their m/z values (x-axis) and 
their HPLC retention time reflecting their hydrophobicity (y-axis).  
 
RESULTS 
Venom Protein Characterisation 
Initially, a 1D-PAGE of all venoms was performed to determine overall venom protein 
profiles. It was found that the six ant venoms all had unique protein compositions (Fig. 1A). 
N. commutata venom contained the highest number of proteins in the range 10–250 kDa, 
while E. tuberculatum venom also had a high number of proteins mainly in the range 10–80 
kDa. The remaining venoms all had diverse and often complex protein profiles apart from O. 
hastatus, with only three distinct protein bands. Despite this clear heterogeneity in protein 
composition, the 1D-PAGE electrophoretic protein profiles revealed similarities among all six 
venoms (red boxes in Fig. 1A). For example, using nanoLC-ESI-QTOF MS/MS the ca. 90 kDa 
band seen in all venoms was identified as dipeptidyl peptidase IV in all cases except O. 
hastatus. Another common feature of most venoms was the presence of bands below ca. 13 
kDa.  
To identify these proteins, 2D-PAGE was performed on the venoms of N. commutata 
and E. tuberculatum. The remaining venoms were not investigated due to the limited 
amount of material. The 2D-PAGE spot patterns obtained after flamingo staining are 
depicted in Fig. 1B-C. The 2D gel of N. commutata venom had a large cluster of low 




lower right corner of the 2D gel at ca. pH 10. This was not seen with E. tuberculatum venom 
that had a greater number of higher molecular weight proteins, particularly ca. 90 kDa (Fig. 
1C). Nevertheless, there were several similarities between the two gels, such as very few 
acidic proteins. Both gels also had several spots with isoforms, such as those at 15 kDa in 
both venoms (e.g. N. commutata spots 9–11, E. tuberculatum spots 1–5), ca. 40 kDa for N. 
commutata (spots 13–16, 24) and ca. 80 kDa for E. tuberculatum at neutral pH. 
Due to the limited number of sequenced ant genomes, the generated nanoLC-ESI-QTOF 
MS/MS data were initially searched with Mascot, however no significant hits were seen. 
Therefore all data, including peptides that were identified by de novo sequencing in PEAKS 6, 
were searched against the NCIBnr database using PEAKS 6. The results of this search are 
summarised in Tables 1 and 2. From all the spots subjected to MS/MS analysis, 14 of the 26 
N. commutata and 14 of the 25 E. tuberculatum 2D gel spots analysed matched to proteins. 
None of these were proteins from the ants investigated, due to no entries being present for 
those species in databases. The remaining spots could not be matched to any known ant or 
other hymenopteran proteins, despite the numerous high quality MS/MS spectra and de 
novo peptide sequences generated, including 136 spectra from spot 8 of the N. commutata 
gel. Several of the spots were matched to proteins using a single peptide, the MS/MS spectra 
for these spots have been included in the supporting information file as supplementary 
Figures S2-S16). 
Of all the matches, three proteins were common to both gels. Firstly, phospholipase A2 
(PLA2) proteins were identified, although in completely different positions in the gels from 
the two different species. The E. tuberculatum PLA2 was identified at ca. pI 7 and mass of ca. 
15 kDa (Fig. 1C; spot 2). However, the N. commutata PLA2 was identified at a pI of 10 and 




protein common to both species was venom acid phosphatase, in N. commutata it was 
found in both spots 2 and 10 and in E. tuberculatum it was found in spots 13–15. The third 
protein common to both venoms was identified as dipeptidyl peptidase. Although this 
protein was not identified in the 2D gel of N. commutata, it was detected from the 1D gel 
slice (Fig. 1A). The mass of this protein was ca. 90 kDa in the 1D gels from both E. 
tuberculatum and N. commutata venom (Fig. 1A) as well as in the 2D gel of E. tuberculatum 
venom (Spot 18 – 23, Fig. 1C). 
In both venoms, the mass of some spots on the gel did not correspond to the exact 
theoretical mass of their assigned protein. For example, N. commutata spot 10 is at ca. 15 
kDa and pI of 6, which is ca. 3 kDa lighter than the predicted protein, although a similar pI. 
One spot that seems to be far from the predicted position of the protein is E. tuberculatum 
spot 1, as seen in Fig. 1C. It is at approximately 15 kDa on the gel and at approximately pH 8. 
This is significantly different to the assigned protein’s calculated mass of 91 kDa and pI of 8, 
as indicated in Table 2. This is most likely the result of post-translational modification, where 
the produced protein has undergone proteolysis, either for activation of function or 
degradation.  
Ant Venom Peptide Characterisation  
Whole Venom C18 RP-HPLC Separation. The venom of each ant was separated using 
RP-HPLC in order to reveal the complexity of the venoms while avoiding possible ion 
suppression effects known to occur in electrospray when using complex mixtures of peptides 
such as venoms. This initial separation step revealed complex chromatographic profiles (Fig. 




brunneum, appeared to contain quite hydrophilic peptides, as most of the peptides eluted 
early in the chromatogram at acetonitrile concentrations < 30%. 
MALDI-TOF MS Matrix optimisation. Our recent work has shown that DHB, sinapinic 
acid, caffeic acid and 2,4,6-trihydroxyacetophenone (THAP) are poor MALDI matrices for the 
automated detection of ant venom peptides and that FA and CHCA allow for the detection of 
the greatest number of peptides with the highest intensities38. Accordingly, initial 
experiments tested four different combinations of these two matrices to determine the best 
one to use for the remainder of the study: CHCA alone, ionic CHCA, FA alone, and FA in 
combination with CHCA. Of these matrices, the matrix that covered the largest mass range 
was FA (Fig. 3A). However, the matrix yielding the highest peptide count was CHCA (Fig. 3B), 
therefore, all remaining venoms investigated were analysed with both CHCA and FA.  
Number of Ant Venom Peptides and Mass distribution. Each HPLC fraction from the six 
venoms was spotted onto a MALDI target with either CHCA or FA matrix to determine the 
number of peptides per fraction and their mass distribution. Although the ant venom RP-
HPLC fractions were seemingly homogenous, with sharp peaks, several peptides were often 
observed in the same fraction when further resolved by MALDI-TOF MS. There were clear 
differences in the abundance of masses from each chromatographic peak, as well as 
differences in the mass range of peptides detected and intensities between the two 
matrices. A single RP-HPLC fraction mostly contained multiple signal peaks that 
corresponded to different masses. For example, 37 masses were observed in ƒ10 from N. 
commutata venom using FA and 26 masses using CHCA (Fig. 4A). Furthermore, many low UV 
absorbance peaks from the RP-HPLC displayed significant numbers of peptides (e.g. 35 




sometimes only had low numbers of peptides in their MALDI spectrum using either CHCA or 
FA. For example, N. commutata ƒ21 contained only a single high intensity mass at 3364.9 
m/z (Fig. 4C). Overall, FA appeared to be better at detecting peptides in the poneroid 
venoms, and was more efficient at detecting lower molecular weight peptides below 1800 
Da in the formicoid venoms. However, CHCA was better at detecting peptides in formicoid 
venoms above 1800 Da (Fig. 3C and shaded area of Fig. 8Ab). 
Frequency histograms in 100 Da bins were constructed to show the full peptide mass 
distribution of all masses detected. The data showed that, in general, ponerine ant venoms 
have peptides with similar masses, with most of the peptides below 4 kDa (Fig. 5). In 
contrast, the formicoid venoms appear to have a broader peptide mass range with a 
significant number of peptides in the range 4–9 kDa (Fig. 6). Peptide peak assignment 
resulted in between 54 (E. brunneum venom using FA matrix) and 1032 (N. commutata 
venom using FA matrix) distinguishable peptide masses for the six ant venoms. The two 
matrices gave similar numbers of peptides, with N. commutata being the only venom to 
have markedly different peptide counts using the two matrices.  
Despite the relatively high peptide counts, there exists the possibility that the two 
matrices were detecting different peptides. Using the separate mass lists created using CHCA 
and FA matrices, masses common to both data sets (±1 Da) were identified using an in-house 
mass-matching Microsoft Excel spread sheet. This analysis revealed a large number of 
peptides that were only detected using one of the two matrices. For example, with N. 
commutata venom only 245 peptides were detected using both FA and CHCA from a total of 
1032 peptides detected using FA alone (24%) and 574 peptides using CHCA alone (43%). This 




alone. Together, the total mass count for N. commutata was therefore 1361 peptides 
(245+787+329). The data for all six venoms is presented in the form of area-proportional 
Euler plots in Fig. 7.  
Inter-Species Variations in Peptide Masses. If ant venoms are to be exploited as 
chemical libraries of unique peptides, it is important to determine if there is sufficient 
peptide heterogeneity between various ant venoms both across, and within, ant sub-
families. Firstly, LC-MALDI-TOF mass spectrometry revealed that all ant venoms investigated 
in the present study showed differences in the broad distribution of masses within the range 
1–10 kDa, with limited overlap (see Fig. 5–7). Using the same mass lists generated from LC-
MALDI-TOF MS, an analysis of masses common to different venoms was undertaken. 
Comparisons were made between ants belonging to the poneroid clade and those belonging 
to the formicoid clade. Analyses were carried out using both CHCA and FA as MALDI matrices 
to negate any bias in peptide identification. 
Area-proportional Euler plots (Fig. 8) revealed only limited overlap of masses between 
ants from the same clades, as only 16 peptides were common to all three poneroid ants and 
only 2 peptides common between the three formicoid ants using CHCA matrix. These 
numbers were similar to those obtained using FA. In general, the poneroid ants appeared to 
have more peptides in common, compared to formicoid ants, with O. hastatus and N. 
commutata sharing the highest number of peptides. 
Disulfide Bond Identification. Peptides with disulfide bonds are highly stable and 
inherently more resistant to proteases29. In order to identify disulfide-bonded peptides 
present in each ant venom, individual LC fractions were spotted on a MALDI target plate 




Fractions were also analysed using the non-reducing matrix CHCA in reflector mode for 
comparison purposes. Each peptide peak obtained with the 1,5-DAN matrix was then 
analysed for a +2 Da, or greater, shift from the native mass obtained using CHCA matrix (see 
Supplementary Figure S1).  
The six venoms were found to contain variable numbers of disulfide-bonded peptides. 
This ranged from 2 disulfide-bonded peptides in M. gulosa venom to 28 disulfide-bonded 
peptides in E. tuberculatum venom (Fig. 9A-F). These peptides were usually of low mass 
(typically < 3 kDa) and distributed across the full HPLC chromatogram. The one exception 
was E. tuberculatum venom where disulfide-bonded peptides were detected in two distinct 
groups in the ranges 1–2 kDa and 3–4 kDa (Fig. 9G). As a percentage of the total number of 
peptides, N. apicalis had the greatest proportion of disulfide-bonded peptides (10.2%), 
followed by O. hastatus (9.0%), E. tuberculatum (7.6%), E. brunneum (5.0%), N. commutata 
(3.7%) and M. gulosa (1.4%). What can also be seen in the 2D landscapes in Fig. 9A-F is that 
multiple peptides co-elute in each LC fraction, with some fractions containing more than 50 
peptides. It can also be seen that peptide mass distribution is independent of the RP-HPLC 
retention time (hydrophobicity). 
 
DISCUSSION 
Until recently, knowledge of the composition and properties of ant venoms was limited 
despite the fact that ants are amongst the most widespread of all social insects39. The 
present study constitutes the first characterisation and comparison of the proteome and 




Ant Venom Proteomes 
The 1D- and 2D-PAGE gels confirmed the complexity of ant venom proteomes as well as the 
broad inter-species variation in protein expression. The 2D-PAGE separation of both N. 
commutata and E. tuberculatum resulted in over 70 spots being resolved, significantly higher 
than the 25 spots previously described from S. invicta venom, one of the only ant venoms on 
which a 2D-PAGE has been performed 16, 24. Not surprisingly, there were some proteins that 
were shared between N. commutata and E. tuberculatum venoms after examination by 2D-
PAGE. The 90-kDa protein band present in all six venoms from the 1D-PAGE and confirmed in 
E. tuberculatum by 2D-PAGE, was identified as dipeptidyl peptidase IV. There was also a 
band common to all six venoms at ca. 24 kDa in the 1D-PAGE gels, identified as a PLA217, 40. 
This was confirmed by the nanoLC-ESI-QTOF MS/MS identification of PLA2 in both 2D-PAGE 
gels around this molecular weight range. This is a common allergenic protein of ant 
venoms17 and other hymenopterans41, although the PLA2 from the fire ant Solenopsis invicta 
is not considered as an allergenic protein42.  
Overall, the majority of spots were assigned to proteins from hymenopteran species, 
where there is a high conservation of protein sequences, especially between bees, wasps 
and ants43, 44. For example, the known insect venom allergen lysosomal acid phosphatase, 
also found in honeybees was identified in both ant venoms45-47. An interesting protein that 
was identified in the N. commutata gel was the antimicrobial, insecticidal and haemolytic 
peptide ponericin. This peptide was first isolated from the venom of the closely related ant 
N. goeldii, from the same genus11, and has been found in other ants15. This protein was 
identified in several spots throughout the gel which suggests the presence of a precursor 




A small number of the spots were identified as contaminants or artifacts of the venom 
extraction procedure, as the identified proteins are not believed to represent venom peptide 
toxins. For example, actin present in the N. commutata venom is most likely a contaminant 
of the exoskeleton48 or reservoir gland49 while endochitinase present in E. tuberculatum 
venom hydrolyses chitin, an important protein for insect growth and morphogenesis50. The 
enzyme trehalase identified in N. commutata venom is also believed to be another 
contaminant, as it is a haemolymph protein involved in the rapid supply of energy for insects 
by converting trehalose to glucose51. 
Importantly, however, a large number of the peptides had no similarity to any known 
sequences, which highlights the uniqueness of ant venom and also the low number of 
available sequences in protein sequence databases. This problem has been encountered by 
other studies looking at hymenopteran venoms23, 39, 52. Moreover, there was a lack of 
separation of the basic, low mass peptides especially those present in N. commutata venom; 
hence, the 2D-PAGE technique was unable to resolve the identity of these peptides resulting 
in the need to employ an alternative method for peptide characterisation. 
Ant Venom Peptidomes 
The venoms of ants and other hymenoptera are known sources of biologically active, low 
molecular weight peptides3, 53, 54. Unlike snakes, spiders, scorpions and marine cone snails37, 
55-57, most ant venom peptidomes remain barely explored. Accordingly, the present study 
represents the first in-depth study of a range of ant venom peptides using highly sensitive 
MS technologies. 
MALDI Matrix Optimisation. Numerous matrix candidates have been evaluated but 




confirmed recent reports that different matrices yield different spectra in MALDI-TOF MS62, 
63. We found that CHCA and FA matrices gave the highest peptide counts with the broadest 
mass distribution, which is in accord with previous studies38. Moreover, the range of 
peptides detected by the two matrices revealed that FA was most suited for poneroid ant 
venoms and was slightly more effective at detecting low mass peptides < 1800 Da in 
formicoid venoms, whilst CHCA was better at detecting peptides in formicoid venoms with a 
wider distribution of masses, e.g. E. tuberculatum and M. gulosa (Fig. 7 and 8). It was also 
determined that FA resulted in the formation of fewer adducts compared to CHCA (Fig. 3B) 
as has been previously reported64. This is most likely due to its increased tolerance to salts 
and other impurities65. Nevertheless, a consistent difference in signal intensity was noted 
which has been reported to be higher with CHCA65.  
Ant Venom Peptide numbers and Distribution. The presence of higher abundance 
peptides and proteins in the sample, results in undetected or unresolved signals from quasi-
isobaric peptides and lower abundance peptide components. Accordingly, ant venoms were 
subjected to RP-HPLC separation prior to MALDI-TOF MS, revealing a complex mixture of 
peptides due to the separation and thus increased detection of trace levels of peptides. In 
addition, this overcame the ion suppression phenomenon by reducing the number of co-
ionised peptides in the mass spectrometer source37, 66. 
The different ant venoms did not follow the same mass distribution, reflecting their 
peptide diversity. This is not unique to ants, as both bimodal37 and unimodal67 distributions 
have been previously reported with other venoms. Most of the ant venoms analysed have 
the majority of their peptides in the low molecular weight range (1–4 kDa). This suggests 
that ant venoms have peptides that are overall smaller than the peptidic component of 




spiders (3–5 kDa and 6.5–8.5 kDa)70 but not marine cone snails (0.5–3.5 kDa)55. However, 
formicoid ant venoms seem to be more complex than poneroid ant venoms and possess 
some larger peptides with masses up to 8 kDa. These results confirm the conclusions of 
previous studies about ant venom peptides using lower resolution MALDI-TOF MS than the 
present study38, 53. However, we found that the poneroid ant N. apicalis has a complex 
venom despite the fact that it is a highly specialised predator of only Syntermes termites71. 
Its venom complexity is comparable to some spider and cone snail venoms55, 72. This 
suggests that predation is not the primary factor in venom composition, and that defence 
against predators and pathogens may play a larger role in the diversification of ant venom 
toxins. 
Given the paucity of data on ant venom peptides, the present study highlights that the 
enormous biodiversity of ant venoms remains almost completely unexplored. If one assumes 
each species of ant has on average 600 unique venom peptides (average of the six ant 
venoms), the total biodiversity present from around 9000 species (ca. 70% of the total 
13,000 extant species) of venomous ants in the world is ca. 5,400,000 distinct peptides (Aili 
et al., 2014). Thus, ant venoms represent an enormous pharmacological library that is 
significantly larger than scorpions (ca. 100,000 peptides)57 and marine cone snail venoms 
(ca. 500,000 peptides)55 but is comparable to that of spiders (ca. 10,000,000 peptides)37. Of 
course, this fails to account for common peptide masses across all species (Fig. 8). Hence a 
more conservative estimation of ant venom peptide biodiversity is around 2,000,000+ 
peptides. To place this potential resource in perspective, only 75 peptides from the 
enormous chemical library of ant venom peptidomes have been described to date, 




Disulfide-bonded Venom Peptides. Disulfide bonds render peptides very stable and 
resistant to a number of proteases and environmental extremes28, 73. This is an 
advantageous feature and consequently has become a focus in the search for stable 
therapeutic or insecticidal peptide toxins28, 73. Indeed, all eight venom-derived drugs on the 
pharmaceutical drug market contain between 1–14 disulfide bonds73. Furthermore, other 
venomous animals such as cone snails, scorpions and spiders contain a high proportion of 
disulfide rich peptides37, 73-75. While the present study confirms previous findings that ant 
venom is believed to be a rich source of small linear peptides53, disulfide-bonded peptides 
are minor components of ant peptidomes. However, biological activities and functions of 
these reticulated peptides still remain unknown and should be investigated in future studies 
as potential sources of insecticides. 
 
CONCLUDING REMARKS 
This proteomic-based study has revealed not only the vast complexity of ant venom proteins 
and peptides but also their inter- and intra-family variation. The mass range of ant venom 
peptides, particularly those from poneroid ants, is lower than that of peptides from other 
venoms, indicating likely novel structures and pharmacologies. The peptide mass 
distributions varied across ant clades and between different ant genera from the same 
clade, reflecting their peptide diversity. Also given that some ant venoms were complex 
despite only preying upon one prey species suggest that there are likely a wide variety of 
bioactive molecules involved in predator defence, communication and host defence against 
infection. This peptide diversity highlights the utility of ant venoms as novel chemical 






Methodology for the identification of disulphide-bonded peptides as well as annotated 
spectra from 2D gel spots where a protein was identified from a single peptide have been 
included in the supporting information. 
Supplementary Figure S1 Identification of disulfide-bonded peptides with the 
use of 1,5-DAN matrix. 
Page S3 
Supplementary Figure S2 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 2 used to match against 
Hymenopteran proteins. 
Page S4 
Supplementary Figure S3 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 5 used to match against 
Hymenopteran proteins. 
Page S5 
Supplementary Figure S4 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 8 used to match against 
Hymenopteran proteins. 
Page S6 
Supplementary Figure S5 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 10 used to match against 
Hymenopteran proteins. 
Page S7 
Supplementary Figure S6 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 15 used to match against 
Hymenopteran proteins. 
Page S8 
Supplementary Figure S7 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 17 used to match against 
Hymenopteran proteins. 
Page S9 
Supplementary Figure S8 Annotated MS spectra of the two peptides from N. 
commutata 2D gel spot 18 used to match against 
Hymenopteran proteins. 
Page S10 
Supplementary Figure S9 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 19 used to match against 
Hymenopteran proteins. 
Page S11 
Supplementary Figure S10 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 23 used to match against 
Hymenopteran proteins. 
Page S12 
Supplementary Figure S11 Annotated MS spectra of a peptide from N. 
commutata 2D gel spot 24 used to match against 
Hymenopteran proteins. 
Page S13 
Supplementary Figure S12 Annotated MS spectra of a peptide from E. 
tuberculatum 2D gel spot 1 used to match against 
Hymenopteran proteins. 
Page S14 
Supplementary Figure S13 Annotated MS spectra of a peptide from E. 
tuberculatum 2D gel spot 2 used to match against 
Hymenopteran proteins. 
Page S15 
Supplementary Figure S14 Annotated MS spectra of the two peptides from E. 






Supplementary Figure S15 Annotated MS spectra of a peptide from E. 
tuberculatum 2D gel spot 15 used to match against 
Hymenopteran proteins. 
Page S17 
Supplementary Figure S16 Annotated MS spectra of a peptide from E. 





Financial support for this study was provided by an Australian Postgraduate Award to Samira 
R. Aili, the Programme Convergence 2007-2013, Région Guyane from the European 
Community (BI-Appli, 115/SGAR-DE/2011/052274) to Alain Dejean and an Investissement 




ACN, acetonitrile; C7BzO, 3-(4-heptyl)phenyl-3-hydroxypropyl) dimethylammoniopropane 
sulfonate; 1,5-DAN, 1,5-diaminonapthalene; CHCA, α-cyano-4-hydroxycinnamic acid; FA, 
ferulic acid; HGD, Hymenopteran Genome Database; IEF, isoelectric focussing; ionic CHCA, 
N-tert-butyl-N-isopropyl-N-methylammonium α-cyano-4-hydroxycinnamate; IPG, 
immobilized pH gradient, LC-ESI-QTOF MS, liquid chromatography electrospray ionization 
quadrupole time-of-flight mass spectrometry; MALDI-TOF MS, matrix-assisted laser-
desorption ionization time-of-flight mass spectrometry; PLA2, phospholipase A2; RP-HPLC, 
reverse-phase high pressure liquid chromatography; SDS-PAGE, sodium dodecyl sulphate 
polyacrylamide gel electrophoresis; TFA, trifluoroacetic acid. 
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Table 1. Protein assignment of N. commutata venom 2D-PAGE spots identified by nanoLC-ESI-QTOF MS/MS. 
2D Gel 
spot 













     Peptide 
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Peptide Sequence 






















































Venom acid phosphatase 
 
Putative uncharacterized protein 
Camponotus floridanus 
 










































Testicular acid phosphatase-like 
protein 















































* MS/MS peptide sequences were searched using PEAKS software against the NCBInr database restricted to Hymenopterans. Protein matches from the NCBInr 
database with the highest coverages are shown. Theoretical mass and pI were determined using Protparam in ExPASy 76. #Spectra for these sequences have 
been included in the Supporting Information for Publication as Supplementary Figures S2-S11. Spots with no matches: 3, 4, 6, 7, 9, 11, 12, 16, 21, 22, 25, 26. 
  


































Arylsulfatase B  
 
 
Actin-5, muscle-specific  
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*MS/MS peptide sequences were searched using PEAKS software against the NCBInr database restricted to Hymenopterans. Protein matches from the NCBInr database 
with the highest coverages are shown. Theoretical mass and pI were determined using Protparam in ExPASy [75]. # Spectra for these sequences have been included in the 
Supporting Information for Publication as Supplementary Figure S12-S16. Spots with no matches: 3, 4, 5, 6, 8–12, 16 and 24. 













FIGURE LEGENDS  
Figure 1. 1D and 2D SDS-PAGE gels of representative ant venoms. (A) 1D gel showing 
molecular weight markers (MW), and reduced and alkylated 100 µg samples of N. 
commutata (Nc), N. apicalis (Na), O. hastatus (Oh), E. tuberculatum (Et), E. brunneum (Eb) 
and M. gulosa (Mg). The red box highlights a conserved protein band across the six species. 
(B-C) 2D SDS-PAGE of reduced and alkylated N. commutata (B) and E. tuberculatum (C) 
whole venom. A 300 µg sample of crude venom was subjected to isoelectric focusing on an 
11 cm pH 3–10 IEF strip. All gels were separated by a Tris-glycine (4–20%) SDS-PAGE and 
stained with Flamingo. Protein spots (circled) were excised for identification by nanoLC-ESI-
QTOF MS/MS and de novo peptide sequencing.  
Figure 2. RP-HPLC chromatograms of poneroid and formicoid ant venoms. Venoms were 
separated by analytical C18 RP-HPLC using an ACN/0.085% TFA gradient of 1%/min (grey 
dotted line) at 1 ml/min. Panels show the chromatographic elution profile of venoms from 
the poneroid ants (A) N. commutata, (B) N. apicalis and (C) O. hastatus, and the formicoid 
ants (D) E. tuberculatum (E) E. brunneum and (F) M. gulosa. Note the different gradient in 
panel E for E. brunneum venom. Chromatographic peaks were monitored at 215 and 280 nm 
(only absorbance at 215 nm is shown for clarity). MALDI spectra of the numbered HPLC 
fractions (ƒ) from N. commutata (Panel A) are shown in Fig. 4.  
Figure 3. Number and distribution of E. tuberculatum venom peptides detected with 
different MALDI matrices. (A) Box-and-whisker plot depicting the mass distribution of 
peptides obtained with the different MALDI matrices; (B) Total peptide counts from all RP-
HPLC fractions using the matrices CHCA, FA, a combination of CHCA and FA, ionic CHCA and 
1,5-DAN before, and after, removal of adducts, dimers and doubly charged species; (C) Box-
and-whisker plot showing ranges of peptide masses determined by CHCA (cyan boxes) and 
FA (beige boxes) matrices from the six venoms. The bottom and top of each box in panels A 
and C represents the first and third quartiles, respectively, while the band and cross inside 
each box represents the median and mean masses, respectively. The ends of the whiskers 
represent the 5–95 percentile range while the closed circles represent masses outside the 5–




Figure 4. Representative MALDI-TOF MS spectra of N. commutata RP-HPLC fractions. MS 
Spectra were obtained in positive linear mode and fractions are labelled according to the RP-
HPLC chromatogram shown in Fig. 2A as ƒ10 (A), ƒ4 (B), and ƒ21 (C). Left-hand panels labelled 
‘a’ with cyan shading were obtained using CHCA matrix, while right-hand panels labelled ‘b’ 
with beige shading were obtained using FA matrix.  
Figure 5. LC-MALDI-TOF mass profile of the poneroid ants N. commutata, N. apicalis and O. 
hastatus. Histograms show the abundance of peptide masses in each venom sorted into 100 
Da mass bins (columns; left-hand ordinate axis) and the cumulative total of peptide masses 
in each venom (circles; right-hand ordinate axis). Shaded areas represent 5–95% of the total 
number of peptides. (Aa-Ca) Peptide masses obtained using CHCA matrix, (Aa) N. 
commutata, (Ba), N. apicalis and (Ca) O. hastatus. (Ab-Cb) Peptide masses obtained using FA 
matrix, (Ab) N. commutata, (Bb), N. apicalis and (Cb) O. hastatus. Total peptide counts are 
indicated in the upper right-hand corner of each panel. All lateral and front images of the 
ants investigated were taken by Ryan Perry and can be found at www.AntWeb.org. 
Figure 6. LC-MALDI-TOF mass profile of the formicoid ants E. tuberculatum, E. brunneum and 
M. gulosa. Histograms show the abundance of peptide masses in each venom sorted into 
100 Da mass bins (columns; left-hand ordinate axis) and the cumulative total of peptide 
masses in each venom (circles; right-hand ordinate axis). Shaded areas represent 5–95% of 
the total number of peptides. (Aa-Ca) Peptide masses obtained using CHCA matrix, (Aa) E. 
tuberculatum, (Ba) E. brunneum (Ca) M. gulosa. (Ab-Cb) Peptide masses obtained using FA 
matrix, (Ab) E. tuberculatum, (Bb) E. brunneum (Cb) M. gulosa. Total peptide counts are 
indicated in the upper right-hand corner of each panel. Lateral and front images of the ants 
investigated were taken by April Nobile, Estella Ortega, and Zach Lieberman and can be 
found at www.AntWeb.org. 
Figure 7. Area-proportional Euler plots depicting numbers of shared and distinct peptides. 
Shared peptides were defined as being within ±1 Da. Spectra were acquired with CHCA 
(cyan) and FA (beige) MALDI matrices. The numbers within the circles indicate the number of 
unique peptides detected employing that particular matrix. The total number of peptides 




proportional Euler plots depicting overlapping peptide masses from multiple venoms were 
constructed using Venn diagram plotter. 
 
Figure 8. (A) Cumulative total of peptides detected using CHCA (cyan circles) or FA (beige 
circles) from the poneroid ants N. commutata, P. apicalis and O. hastatus (Aa) or formicoid 
ants O. hastatus, O. brunneum and M. gulosa (Ab). Panel Ab grey shaded area, FA was more 
efficient at detecting lower molecular weight peptides below 1800 Da in the formicoid 
venoms. (B-C) Common peptides between ant clades. Area-proportional Euler plot depicting 
species variation in numbers of shared and distinct peptides (±1 Da) determined using 
MALDI-TOF MS. Left hand panels labelled ‘a’ contains data from poneroid ants; right hand 
panels labelled ‘b’ show a comparison of the formicoid ant data. Panels B refer to the venom 
peptides detected using CHCA matrix, while Panel C represents peptides detected using FA 
matrix.  
Figure 9. Determination of disulfide-bonded peptides in ant venoms. MALDI-TOF MS analysis 
of individual RP-HPLC fractions from five ant venoms. (A-F) 2D Landscape plots where the 
abscissa represents the C18 RP-HPLC retention time while the ordinate shows the masses 
obtained by MALDI-TOF MS. Cyan circles represent the non-disulfide-bonded peptides in the 
venom. Red triangles indicate peptides with a disulfide bond. Total number of disulfide-
bonded peptides in each venom is indicated in the top right-hand box in each panel (S-S). (A) 
N. commutata, (B) N. apicalis, (C) O. hastatus, (D) E. tuberculatum, (F) E. brunneum and (F) 
M. gulosa. The shaded areas represent 5–95% of the total number of peptides. (G) Scatter 
dot plot showing all disulfide-bonded masses from each venom; the dotted horizontal line 
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